Full Text View
Tabular View
No Study Results Posted
Related Studies
Vaccine Therapy in Treating Patients With Advanced Melanoma
This study has been completed.
Study NCT00705640   Information provided by University of Virginia

First Received on June 25, 2008.   Last Updated on October 12, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Intraocular Melanoma
Malignant Conjunctival Neoplasm
Melanoma (Skin)
Additional conditions recognized in this trial
Conjunctival Neoplasms
Melanoma
Neoplasms
Uveal Neoplasms
More general conditions related to this trial
Conjunctival Diseases
Eye Diseases
Eye Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Germ Cell and Embryonal
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Nevi and Melanomas
Uveal Diseases
Interventions listed in this trial
incomplete Freund's adjuvant
tetanus toxoid helper peptide
biopsy
Additional drug interventions recognized in this trial
Adjuvants, Immunologic
Freund's Adjuvant
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
University of Virginia
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services